OPKO HEALTH INC
For the period ended Dec 31, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 1, 2024
OPK$1.71-1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $95,881 | $153,191 |
| Accounts receivable, net | 123,379 | 127,312 |
| Inventory, net | 65,697 | 74,060 |
| Other current assets and prepaid expenses | 24,519 | 39,962 |
| Total current assets | 309,476 | 394,525 |
| Property, plant and equipment, net | 75,429 | 82,879 |
| Intangible assets, net | 740,283 | 823,520 |
| In-process research and development | 195,000 | 195,000 |
| Goodwill | 598,260 | 595,851 |
| Investments | 16,082 | 28,080 |
| Operating lease right-of-use assets | 68,088 | 38,725 |
| Other assets | 9,080 | 8,679 |
| Total assets | $2,011,698 | $2,167,259 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $69,677 | $66,993 |
| Accrued expenses | 90,086 | 98,269 |
| Current maturities of operating leases | 12,996 | 11,628 |
| Current portion of convertible notes | — | 3,050 |
| Current portion of lines of credit and notes payable | 27,293 | 33,540 |
| Total current liabilities | 200,052 | 213,480 |
| Operating lease liabilities | 54,140 | 27,963 |
| Convertible notes | 214,325 | 210,371 |
| Deferred tax liabilities | 126,773 | 126,426 |
| Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit | 27,189 | 27,371 |
| Total long-term liabilities | 422,427 | 392,131 |
| Total liabilities | 622,479 | 605,611 |
| Equity: | ||
| Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 781,936,885 and 781,306,164 shares issued at December 31, 2023 and 2022, respectively | 7,820 | 7,813 |
| Treasury Stock, - 8,655,082 shares at December 31, 2023 and 2022, respectively | (1,791) | (1,791) |
| Additional paid-in capital | 3,433,006 | 3,421,872 |
| Accumulated other comprehensive loss | (38,030) | (43,323) |
| Accumulated deficit | (2,011,786) | (1,822,923) |
| Total shareholders’ equity | 1,389,219 | 1,561,648 |
| Total liabilities and equity | $2,011,698 | $2,167,259 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.